Northstar Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.45M Buy
2,877
+2,205
+328% +$2.25M 1.07% 25
2026
Q1
$618K Sell
672
-4,006
-86% -$4.06M 0.23% 73
2025
Q4
$5.03M Buy
4,678
+2,565
+121% +$2.45M 1.79% 13
2025
Q3
$1.61M Buy
2,113
+1,676
+384% +$1.25M 0.66% 47
2025
Q2
$341K Buy
437
+1
+0.2% +$777 0.17% 83
2025
Q1
$360K Hold
436
0.24% 76
2024
Q4
$337K Sell
436
-1
-0.2% -$828 0.17% 80
2024
Q3
$387K Sell
437
-2
-0.5% -$1.8K 0.2% 77
2024
Q2
$397K Hold
439
0.23% 70
2024
Q1
$339K Sell
439
-53
-11% -$37.7K 0.21% 73
2023
Q4
$287K Buy
492
+2
+0.4% +$1.17K 0.17% 74
2023
Q3
$263K Sell
490
-453
-48% -$233K 0.19% 75
2023
Q2
$442K Sell
943
-1,670
-64% -$700K 0.29% 55
2023
Q1
$897K Sell
2,613
-1,814
-41% -$612K 0.67% 35
2022
Q4
$1.62M Buy
4,427
+842
+23% +$299K 1.28% 14
2022
Q3
$1.16M Buy
3,585
+1,470
+70% +$466K 1.04% 19
2022
Q2
$686K Sell
2,115
-33
-2% -$9.91K 0.51% 29
2022
Q1
$615K Sell
2,148
-351
-14% -$90.3K 0.4% 55
2021
Q4
$690K Buy
+2,499
New +$634K 0.41% 45
2021
Q3
Sell
-2,163
Closed -$496K 84
2021
Q2
$496K Buy
2,163
+229
+12% +$46K 0.31% 59
2021
Q1
$361K Sell
1,934
-101
-5% -$19.8K 0.28% 65
2020
Q4
$344K Buy
+2,035
New +$304K 0.29% 69

Other funds holding LLY

Northstar Advisory Group's LLY Position: Q2 2026 in Review

Northstar Advisory Group increased its Eli Lilly (LLY) stake by 328% in Q2 2026, buying an estimated $2.25M and bringing the position to 2,877 shares worth $3.45M. The position accounts for 1.07% of the portfolio, ranked #25.

Northstar Advisory Group first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.03M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Northstar Advisory Group held 2,877 shares of Eli Lilly worth $3.45M as of Q2 2026.
  • Northstar Advisory Group bought 2,205 Eli Lilly shares in Q2 2026, an estimated $2.25M.
  • Eli Lilly made up 1.07% of Northstar Advisory Group's portfolio in Q2 2026, its #25 holding.
  • Northstar Advisory Group first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Northstar Advisory Group's Eli Lilly position peaked at $5.03M in Q4 2025.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Northstar Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.